Defective cleavage of membrane bound TGFalpha leads to enhanced activation of the EGF receptor in malignant cells.

Abstract:

:Transforming growth factor alpha (TGFalpha) is widely expressed in malignant as well as normal cells and is involved in regulating cell growth and differentiation. Although processing of TGFalpha has been extensively studied in normal cells, there is little information regarding TGFalpha cleavage in malignant cells. Therefore, we compared the processing of TGFalpha in two human colon carcinoma cell lines. We found that there was a defective cleavage pattern for the TGFalpha precursor resulting in retention of partially processed TGFalpha on the cell surface of both the HCT116a2alphaS3 and CBS4alphaS2 cell lines. This raised the possibility that signaling from the resulting defective cleavage species could differ from that of soluble TGFalpha. The membrane-associated TGFalpha induced higher phosphorylation of EGFR on the cell surface of adjacent cells than equivalent levels of mature TGFalpha. The interaction of membrane bound TGFalpha precursor with the EGFR caused a slower internalization of activated EGFR relative to the internalization of the soluble TGFalpha/EGFR complexes. In addition, the tethered TGFalpha was resistant to the ability of protein-tyrosine phosphatases (PTPs) to reduce EGFR tyrosine phosphorylation, also contributing to higher activation of EGFR. The enhanced activation of EGFR by the tethered form of TGFalpha was reflected by higher activation of Grb2, SHC and Erk downstream mediators of EGF receptor signaling. The higher activation of EGFR by membrane tethered TGFalpha indicates that defective TGFalpha processing provides a mechanism whereby malignant cells can obtain a growth advantage over normal cells.

journal_name

Oncogene

journal_title

Oncogene

authors

Yang H,Jiang D,Li W,Liang J,Gentry LE,Brattain MG

doi

10.1038/sj.onc.1203513

subject

Has Abstract

pub_date

2000-04-06 00:00:00

pages

1901-14

issue

15

eissn

0950-9232

issn

1476-5594

journal_volume

19

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • The E2F5 repressor is an activator of E6/E7 transcription and of the S-phase entry in HPV18-associated cells.

    abstract::High-risk papillomavirus type 18 (HPV18) is one of the less represented HPV types in low-grade lesions of the anogenital tract, whereas it occupies the second place in cervical cancer, where it can be found in 16% of the cases worldwide, after HPV16 present in 54% of them. These epidemiological data indicate that HPV1...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.246

    authors: Teissier S,Pang CL,Thierry F

    更新日期:2010-09-09 00:00:00

  • p73 is transcriptionally regulated by DNA damage, p53, and p73.

    abstract::p73 is a member of the p53 family. Recent studies have shown that DNA damage can stabilize p73 protein and enhance p73-mediated apoptosis in a c-Abl dependent manner. To determine what regulates p73 transcriptionally, we analysed the expression of p73 in several cell lines following genotoxic stresses. We found that p...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204149

    authors: Chen X,Zheng Y,Zhu J,Jiang J,Wang J

    更新日期:2001-02-08 00:00:00

  • CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model.

    abstract::CD97, a member of the adhesion family of G-protein-coupled receptors (GPCRs), complexes with and potentiates lysophosphatidic acid (LPA) receptor signaling to the downstream effector RHOA. We show here that CD97 was expressed in a majority of thyroid cancers but not normal thyroid epithelium and that the level of CD97...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.301

    authors: Ward Y,Lake R,Martin PL,Killian K,Salerno P,Wang T,Meltzer P,Merino M,Cheng SY,Santoro M,Garcia-Rostan G,Kelly K

    更新日期:2013-05-30 00:00:00

  • Structural determinants of the BRCA1 : estrogen receptor interaction.

    abstract::Previously, we showed that the BRCA1 protein interacts directly and functionally with estrogen receptor-alpha (ER-alpha), resulting in the inhibition of estradiol (E2)-stimulated ER-alpha transcriptional activity. The interaction sites were mapped to the N-terminus of BRCA1 (within amino acids (aa) 1-302) and the liga...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208190

    authors: Ma YX,Tomita Y,Fan S,Wu K,Tong Y,Zhao Z,Song LN,Goldberg ID,Rosen EM

    更新日期:2005-03-10 00:00:00

  • Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis.

    abstract::We have recently described the N-terminal RAS association domain family of genes, RASSF7-10. Previously, we cloned the N-terminal RASSF10 gene and demonstrated frequent methylation of the associated 5'-CpG island in acute lymphoblastic leukemia. To characterize RASSF10 gene expression, we demonstrate that in developin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.471

    authors: Hill VK,Underhill-Day N,Krex D,Robel K,Sangan CB,Summersgill HR,Morris M,Gentle D,Chalmers AD,Maher ER,Latif F

    更新日期:2011-02-24 00:00:00

  • ATR mediates cisplatin resistance in a p53 genotype-specific manner.

    abstract::The protein kinase encoded by the ataxia telangiectasia and Rad3-related (ATR) gene is activated by DNA-damaging agents that are frequently used as anticancer therapeutics. Inhibition of ATR expression in cultured cancer cells has been demonstrated to increase sensitivity to chemotherapeutic drugs, including the DNA-c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.624

    authors: Sangster-Guity N,Conrad BH,Papadopoulos N,Bunz F

    更新日期:2011-06-02 00:00:00

  • Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase.

    abstract::We screened cdc2 kinase inhibitors from cultured mediums of micro organisms using purified mouse cyclin B-cdc2 kinase and a specific substrate peptide for cdc2 kinase. A selective inhibitor of cdc2 kinase was isolated from the cultured medium of Aspergillus species F-25799, and identified as butyrolactone I. Butyrolac...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kitagawa M,Okabe T,Ogino H,Matsumoto H,Suzuki-Takahashi I,Kokubo T,Higashi H,Saitoh S,Taya Y,Yasuda H

    更新日期:1993-09-01 00:00:00

  • Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein.

    abstract::The 2;13 chromosomal translocation occurs in most cases of the cancer alveolar rhabdomyosarcoma (ARMS), and juxtaposes the genes encoding the PAX3 and FKHR transcription factors. The resulting chimeric protein PAX3-FKHR is a potent transcriptional activator, and is hypothesized to function as a dominant acting oncogen...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207850

    authors: Xia SJ,Barr FG

    更新日期:2004-09-09 00:00:00

  • Characterization of changes in gene expression associated with malignant transformation by the NF-kappaB family member, v-Rel.

    abstract::In this study, alterations in gene expression patterns have been examined in v-Rel-transformed avian bone marrow cells. Using a conditional v-Rel estrogen receptor chimera (v-RelER) which transforms cells in an estrogen-dependent manner, we constructed subtraction cDNA libraries from v-RelER-transformed bone marrow ce...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201334

    authors: Petrenko O,Ischenko I,Enrietto PJ

    更新日期:1997-10-02 00:00:00

  • Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.

    abstract::The gfi-1 gene encodes a zinc finger containing protein that is specifically expressed in T-lymphocytes and is a frequent target of proviral insertion in T-cell lymphoma provoked by infection with MoMuLV--a non acute transforming retrovirus. Expression of a gfi-1 transgene targeted to T-cells by the lck proximal promo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202191

    authors: Schmidt T,Karsunky H,Gau E,Zevnik B,Elsässer HP,Möröy T

    更新日期:1998-11-19 00:00:00

  • The hepatitis B virus (HBV) pX transactivates the c-fos promoter through multiple cis-acting elements.

    abstract::The hepatitis B virus (HBV) X protein (pX) stimulates transcription regulated by cis-acting elements that control many viral and cellular genes, including the c-myc and the c-fos proto-oncogenes. Using several c-fos promoter deletion mutants, we found the serum-responsive element (SRE) located at -315, the modified TP...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Avantaggiati ML,Natoli G,Balsano C,Chirillo P,Artini M,De Marzio E,Collepardo D,Levrero M

    更新日期:1993-06-01 00:00:00

  • A RasGAP-derived cell permeable peptide potently enhances genotoxin-induced cytotoxicity in tumor cells.

    abstract::Treatment of many cancers relies on the combined action of several genotoxins, but the detrimental effect of these drugs on normal cells can cause severe side effects. One major challenge in anticancer therapy is therefore to increase the selectivity of current treatments toward cancer cells in order to spare normal c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207999

    authors: Michod D,Yang JY,Chen J,Bonny C,Widmann C

    更新日期:2004-11-25 00:00:00

  • Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors.

    abstract::The cochaperone CDC37 promotes the association of HSP90 with the protein kinase subset of client proteins to maintain their stability and signalling functions. HSP90 inhibitors induce depletion of clients, which include several oncogenic kinases. We hypothesized that the targeting of CDC37 using siRNAs would compromis...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.380

    authors: Smith JR,Clarke PA,de Billy E,Workman P

    更新日期:2009-01-15 00:00:00

  • Genetic reporter system for oncogenic Igh-Myc translocations in mice.

    abstract::The Myc-deregulating chromosomal T(12;15)(Igh-Myc) translocation, the hallmark mutation of inflammation- and interleukin 6-dependent mouse plasmacytoma (PCT), is the premier model of cancer-associated chromosomal translocations because it is the only translocation in mice that occurs spontaneously (B lymphocyte lineag...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.150

    authors: Takizawa M,Kim JS,Tessarollo L,McNeil N,Waldschmidt TJ,Casellas R,Ried T,Janz S

    更新日期:2010-07-15 00:00:00

  • Transforming activities of human CSF-1 receptors with different point mutations at codon 301 in their extracellular domains.

    abstract::Replacement of leucine 301 in the human colony stimulating factor 1 receptor (CSF-1R) by serine, threonine, glutamic acid, or proline induced ligand-independent transforming activity in mouse NIH3T3 cells, whereas substitution by phenylalanine, methionine, cysteine, or lysine did not. Serine, glutamic acid, and prolin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Roussel MF,Downing JR,Sherr CJ

    更新日期:1990-01-01 00:00:00

  • A refined molecular taxonomy of breast cancer.

    abstract::The current histoclinical breast cancer classification is simple but imprecise. Several molecular classifications of breast cancers based on expression profiling have been proposed as alternatives. However, their reliability and clinical utility have been repeatedly questioned, notably because most of them were derive...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.301

    authors: Guedj M,Marisa L,de Reynies A,Orsetti B,Schiappa R,Bibeau F,MacGrogan G,Lerebours F,Finetti P,Longy M,Bertheau P,Bertrand F,Bonnet F,Martin AL,Feugeas JP,Bièche I,Lehmann-Che J,Lidereau R,Birnbaum D,Bertucci F,de

    更新日期:2012-03-01 00:00:00

  • 2-deoxyglucose-induced toxicity is regulated by Bcl-2 family members and is enhanced by antagonizing Bcl-2 in lymphoma cell lines.

    abstract::Targeting altered cancer cell metabolism with the glycolysis inhibitor, 2-deoxyglucose (2DG), is a viable therapeutic strategy, but the effects of 2DG on lymphoma cells and the mechanism of action are unknown. Five T-cell lymphoma lines and two B-cell lymphoma lines were shown to be highly sensitive to 2DG. Examinatio...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.454

    authors: Zagorodna O,Martin SM,Rutkowski DT,Kuwana T,Spitz DR,Knudson CM

    更新日期:2012-05-31 00:00:00

  • Growth stimulation of murine fibroblasts by TGF-beta1 depends on the expression of a functional p53 protein.

    abstract::Transforming Growth Factor-beta1 (TGF-beta1) inhibits the proliferation of most cells, but stimulates some mesenchymal cell types, including murine NIH3T3 fibroblasts. We show here that TGF-beta1 growth stimulation of NIH3T3 fibroblasts is reversed when these cells are transformed by SV40 or are transfected with a pla...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202341

    authors: Dkhissi F,Raynal S,Jullien P,Lawrence DA

    更新日期:1999-01-21 00:00:00

  • LncRNA-mediated regulation of cell signaling in cancer.

    abstract::To date, a large number of long non-coding RNAs (lncRNAs) have been recently discovered through functional genomics studies. Importantly, lncRNAs have been shown, in many cases, to function as master regulators for gene expression and thus, they can play a critical role in various biological functions and disease proc...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2017.184

    authors: Peng WX,Koirala P,Mo YY

    更新日期:2017-10-12 00:00:00

  • Hsp90-inhibitor geldanamycin abrogates G2 arrest in p53-negative leukemia cell lines through the depletion of Chk1.

    abstract::Checkpoint protein Chk1 has been identified as an Hsp90 client. Treatment with 100 nM geldanamycin (GM) for 24 h markedly reduced the Chk1 amount in Jurkat and ML-1 leukemia cell lines. Because Chk1 plays a central role in G2 checkpoint, we added GM to G2-arrested Jurkat and HL-60 cells pretreated with 50 nM doxorubic...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210978

    authors: Sugimoto K,Sasaki M,Isobe Y,Tsutsui M,Suto H,Ando J,Tamayose K,Ando M,Oshimi K

    更新日期:2008-05-15 00:00:00

  • Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5.

    abstract::Genomic imprinting at 11p15 is suggested to play a role in certain pediatric tumors such as Wilms' tumor, based on the findings of selective maternal loss of this chromosomal region. Although the allele loss at 11p15 is also frequent in a number of cancers of adults including lung, breast, and bladder cancers, possibl...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kondo M,Matsuoka S,Uchida K,Osada H,Nagatake M,Takagi K,Harper JW,Takahashi T,Elledge SJ,Takahashi T

    更新日期:1996-03-21 00:00:00

  • FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.

    abstract::Targeting Bruton tyrosine kinase (BTK) by ibrutinib is an effective treatment for patients with relapsed/refractory mantle cell lymphoma (MCL). However, both primary and acquired resistance to ibrutinib have developed in a significant number of these patients. A combinatory strategy targeting multiple oncogenic pathwa...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.155

    authors: Li Y,Bouchlaka MN,Wolff J,Grindle KM,Lu L,Qian S,Zhong X,Pflum N,Jobin P,Kahl BS,Eickhoff JC,Wuerzberger-Davis SM,Miyamoto S,Thomas CJ,Yang DT,Capitini CM,Rui L

    更新日期:2016-12-01 00:00:00

  • EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer.

    abstract::EDD (E3 isolated by differential display), located at chromosome 8q22.3, is the human orthologue of the Drosophila melanogaster tumour suppressor gene 'hyperplastic discs' and encodes a HECT domain E3 ubiquitin protein-ligase. To investigate the possible involvement of EDD in human cancer, several cancers from diverse...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206775

    authors: Clancy JL,Henderson MJ,Russell AJ,Anderson DW,Bova RJ,Campbell IG,Choong DY,Macdonald GA,Mann GJ,Nolan T,Brady G,Olopade OI,Woollatt E,Davies MJ,Segara D,Hacker NF,Henshall SM,Sutherland RL,Watts CK

    更新日期:2003-08-07 00:00:00

  • Matrix metalloproteinase processing of PTHrP yields a selective regulator of osteogenesis, PTHrP1-17.

    abstract::Parathyroid hormone-related protein (PTHrP) is a critical regulator of bone resorption and augments osteolysis in skeletal malignancies. Here we report that the mature PTHrP1-36 hormone is processed by matrix metalloproteinases to yield a stable product, PTHrP1-17. PTHrP1-17 retains the ability to signal through PTH1R...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.70

    authors: Frieling JS,Shay G,Izumi V,Aherne ST,Saul RG,Budzevich M,Koomen J,Lynch CC

    更新日期:2017-08-01 00:00:00

  • The adenovirus E1A 289R and 243R proteins inhibit the phosphorylation of p300.

    abstract::A protein of 300 kDa (p300) associates with the adenovirus E1A proteins and has been implicated in the control of cell cycle progression. In mammalian cells, p300 is actively phosphorylated in both quiescent and proliferating cells and its level of phosphorylation increases as it travels from late G1 into M phase. E1A...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Banerjee AC,Recupero AJ,Mal A,Piotrkowski AM,Wang DM,Harter ML

    更新日期:1994-06-01 00:00:00

  • Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer.

    abstract::Neoadjuvant and adjuvant chemotherapies provide survival benefits to breast cancer patients, in particular in estrogen receptor negative (ER-) cancers, by reducing rates of recurrences. It is assumed that the benefits of (neo)adjuvant chemotherapy are due to the killing of disseminated, residual cancer cells, however,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0624-2

    authors: Lan Q,Peyvandi S,Duffey N,Huang YT,Barras D,Held W,Richard F,Delorenzi M,Sotiriou C,Desmedt C,Lorusso G,Rüegg C

    更新日期:2019-04-01 00:00:00

  • Expression and phenotypic alterations caused by an inducible transforming ras oncogene introduced into rat liver epithelial cells.

    abstract::Although transforming ras oncogenes have been implicated as causative factors in liver cell transformation, the exact function and phenotypic alterations generated by the expression of such transforming genes in liver epithelial cells has yet to be defined. We have utilized a retroviral vector system to deliver an ind...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Huber BE,Cordingley MG

    更新日期:1988-09-01 00:00:00

  • NFATc2 is an intrinsic regulator of melanoma dedifferentiation.

    abstract::Melanoma dedifferentiation, characterized by the loss of MITF and MITF regulated genes and by upregulation of stemness markers as CD271, is implicated in resistance to chemotherapy, target therapy and immunotherapy. The identification of intrinsic mechanisms fostering melanoma dedifferentiation may provide actionable ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.355

    authors: Perotti V,Baldassari P,Molla A,Vegetti C,Bersani I,Maurichi A,Santinami M,Anichini A,Mortarini R

    更新日期:2016-06-02 00:00:00

  • p53 point mutation in HPV negative human cervical carcinoma cell lines.

    abstract::Clinical and experimental evidence is consistent with a key role for transforming human papilloma viruses (HPVs) in the aetiology of anogenital carcinoma. Cervical carcinoma does, however, occasionally occur in the absence of HPV sequences (Riou et al., 1990). We have used a direct cDNA/PCR sequencing protocol to anal...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Crook T,Wrede D,Vousden KH

    更新日期:1991-05-01 00:00:00

  • Developmental regulation of intermediate filament and actin mRNAs during myogenesis is disrupted by oncogenic ras genes.

    abstract::Terminal differentiation of skeletal myoblasts is accompanied by down-regulation of vimentin and beta-, gamma-actins and up-regulation of desmin and sarcomeric alpha-actin(s). To investigate whether the normal decline in expression of vimentin and beta-, gamma-actins was coupled to withdrawal of proliferating myoblast...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Olson EN,Capetanaki YG

    更新日期:1989-07-01 00:00:00